Anuj Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 21 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 32.00 M
as on 24-10-2024
- Satisfied Charges ₹ 7.78 M
as on 24-10-2024
- Revenue 10.08%
(FY 2023)
- Profit -23.78%
(FY 2023)
- Ebitda -18.02%
(FY 2023)
- Net Worth 12.45%
(FY 2023)
- Total Assets 0.75%
(FY 2023)
About Anuj Pharmachem
The Corporate was formerly known as Sheetal Warehousing Private Limited. The Company is engaged in the Transport And Logistics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.20 Cr. The company has closed loans amounting to ₹7.78 M, as per Ministry of Corporate Affairs (MCA) records.
Shyam Agrawal and Anuj Agrawal serve as directors at the Company.
- CIN/LLPIN
U63010MH2003PTC140067
- Company No.
140067
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anuj Pharmachem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuj Agrawal  | Director | 05-Jul-2014 | Current |
| Shyam Agrawal | Director | 09-Nov-2010 | Current |
Financial Performance and Corporate Structure Insights of Anuj Pharmachem.
Anuj Pharmachem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.08% increase. The company also saw a substantial fall in profitability, with a 23.78% decrease in profit. The company's net worth Soared by an impressive increase of 12.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anuj Pharmachem?
In 2022, Anuj Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shree Shyam Kamal Steel Industries Private Limited
Active 4 years 11 monthsShyam Agrawal and Anuj Agrawal are mutual person
Fresh Mercantiles Private Limited
Active 14 years 1 monthShyam Agrawal and Anuj Agrawal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karur Vysya Bank Limited Creation Date: 26 Mar 2013 | ₹2.00 Cr | Open |
Karur Vysya Bank Limited Creation Date: 25 Oct 2012 | ₹1.20 Cr | Open |
Punjab National Bank Creation Date: 10 Jul 2004 | ₹7.78 M | Satisfied |
How Many Employees Work at Anuj Pharmachem?
Unlock and access historical data on people associated with Anuj Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anuj Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anuj Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
